Founder of a stealth startup focused on AI-powered longevity drug discovery. Previously worked at Insilico Medicine and Gero, both companies in the AI-driven drug discovery and aging research space.

Founder and CEO of PopVax, an Indian biotech company developing mRNA vaccines and therapeutics using computational protein design. Previously served as an advisor at Pashi.

Stanford CS and Neuroscience student working as Senior Atlantic Fellow at Global Brain Health Institute. Thiel Fellow and Forbes 30 Under 30 recipient focused on breakthrough health technologies.

Yale Professor and founder & CEO of CellType (YC W26), working on AI for drug discovery.

Ex-Palantir engineer who moved into healthcare business development, now co-founder and CEO of Link Mobile.

UBC Presidential Scholar who worked on hardware at Midjourney before founding Mitra Biotechnologies in 2020. Masason Foundation member and Z Fellow.

Duke alum and co-founder of Real. Previously founded Endpoints News (243k subscribers) and invented FierceBiotech during a 47-year journalism career covering biotech and healthcare.

Building the clinical reasoning engine to close the gap between diagnosis and treatment at Latent.

Founder launching an AI-native pharmacy focused on personalized medicine. Part of Y Combinator's S26 batch.

CEO and Co-Founder at Eon.